The short version
- Why people research itApproved for Parkinson's disease and, as a patch, depression; researched for dopamine support and ageing.
- What the evidence isA large randomized result in early Parkinson's disease.
- What to watchSevere headache with a pounding pulse or very high blood pressure.
How Selegiline works
Rat longevity data are real, consistent within one laboratory and not independently replicated at scale. Knoll's 1988 study found treated male rats lived significantly longer, with restored sexual activity, and attributed it to striatal dopamine function (Knoll 1988).
Blocking it keeps dopamine around longer, which is the basis for its use in Parkinson's disease and, as a patch, in depression. Selegiline is described as a catecholaminergic activity enhancer that raises the amount of dopamine and noradrenaline released per nerve impulse, an effect he attributed to the phenylethylamine-derived structure rather than MAO inhibition. That enhancer effect is the reason it has a longevity literature in rats and the reason BPAP was developed as a more potent successor. Selegiline is also converted in the body to metabolites that include L-methamphetamine and L-amphetamine.
- Oral
On the goal map: Catecholamine & dopaminergic drive (Focus, memory & cognition)
Research on Selegiline5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Human (approved prescription drug; randomized trials in Parkinson's disease and, transdermally, depression); animal longevity studies from one laboratory.
Human clinical evidence
A large randomized result in early Parkinson's disease. In DATATOP, 800 untreated early-stage patients were randomized to deprenyl, tocopherol, both or placebo; the interim analysis showed a 57 percent reduction in risk of reaching the disability endpoint that required levodopa (hazard ratio 0.43) and fewer people leaving full-time employment (Parkinson Study Group 1989). Eight years later survival was no different: mortality was about that of an age- and sex-matched population and was unaffected by deprenyl (Parkinson Study Group 1998). The honest summary is a symptomatic delay, not a life-extension result.
A second, separate approval in depression. The transdermal system was approved for major depressive disorder on the strength of five short-term, placebo-controlled trials, whose pooled analysis showed significant effects on core depressive, reverse-vegetative and libido items (Robinson 2007).
Correlative data
Decades of use in Parkinson's clinics and a long off-label anti-ageing history. The anti-ageing use began with Knoll's rat studies and spread through the longevity community; it has no controlled human data in healthy people, and its effect on ageing in humans has not been tested.
How the mechanism reads
Rat longevity data are real, consistent within one laboratory and not independently replicated at scale. Knoll's 1988 study found treated male rats lived significantly longer, with restored sexual activity, and attributed it to striatal dopamine function (Knoll 1988). Both come from the compound's discoverer.
Experimental, animal or cellThe predicted downside follows the pharmacology. An MAO inhibitor interacts with serotonergic drugs (SSRIs, SNRIs, tramadol, dextromethorphan, meperidine) and with sympathomimetics, and its amphetamine-type metabolites matter for blood pressure, sleep and sensitivity to stimulants. Which is where the tyramine problem returns.
Mechanistic
Selegiline safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Any serotonergic drug, including SSRIs, SNRIs, tricyclics, tramadol, meperidine and dextromethorphan, because MAO inhibition can cause serotonin syndrome.
- Sympathomimetic stimulants, decongestants or amphetamines, since MAO inhibition amplifies them and its metabolites are amphetamine-like.
- Uncontrolled high blood pressure or a pheochromocytoma.
- Bipolar disorder or psychosis, as raising dopamine can trigger mania or psychotic symptoms.
- Planned surgery or dental work needing local anesthetic with epinephrine.
What’s expected
- Insomnia, agitation or vivid dreams if taken late, from amphetamine-type metabolites.
- Mild nausea or dizziness on standing in early weeks.
Watch for
- Severe headache with a pounding pulse or very high blood pressure.
- Fever, tremor, sweating and agitation together.
- Hallucinations or new compulsive behavior.
Labs that tell you it’s working
- Prolactin: more dopamine tone suppresses pituitary prolactin.
- Cortisol: raised catecholamines can lift the morning value.
- Comprehensive Metabolic Panel: liver handling and baseline kidney function.
- Homocysteine: levodopa-using patients are the ones who need this watched; relevant if combined.
Irreversible MAO-B inhibitor with amphetamine-type metabolites: the safety profile is the interaction list, and selectivity for MAO-B is lost at higher exposure. PMID 2509910 PMID 9506548 PMID 18007565
Bloodwork to runHow you would know it is working: 6 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Selegiline FAQ4 common questions
- Is Selegiline approved for human use?
- Selegiline is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
- What is Selegiline researched for?
- Approved for Parkinson's disease and, as a patch, depression; researched for dopamine support and ageing.
- Which labs show whether it's doing anything?
- Prolactin; Cortisol; Comprehensive Metabolic Panel; Homocysteine: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Selegiline: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



